With a rise in clinical trials investigating psychedelics for a number of mental health conditions, the UK’s Parliamentary Office of Science and Technology (POST) has issued a rapid response on psychedelic research. In May, the UK saw a parliamentary debate discussing psilocybin access, where a group of crossparty MPs called for the rescheduling of psilocybin … Continue reading UK advisory body issues rapid response on psychedelic research